-
As many as one in three Americans say they would not get a vaccine for the coronavirus even if it were approved by the FDA and available for free. About 35 percent of Americans say they would not receive such a vaccine to guard against the coronavirus, while 65 percent say they would plan to …
-
President Trump on Thursday said he thinks it’s possible there will be a COVID-19 vaccine ready around Election Day in November. “I think in some cases, yes, possible before, but right around that time,” Trump said on Geraldo Rivera’s radio show when asked if he thought a vaccine would be ready by Nov. 3. “We have …
-
The feds will give Sanofi and GlaxoSmithKline up to $2.1 billion to churn out a coronavirus vaccine in the Trump administration’s latest and largest bet on an experimental inoculation. More than half the award announced Friday will help the European drugmakers develop and test their vaccine, while the rest will be used to support manufacturing …
-
Johnson & Johnson kicked off human trials of its experimental COVID-19 vaccine Thursday, after the shots already proved successful in protecting monkeys, the drugmaker announced. Company honchos pointed to a new study which found that five out of six primates who got the single-dose shot were protected from infection when exposed to the coronavirus, as …
-
Drug maker Moderna started the final round of clinical testing for its coronavirus vaccine on Monday, making it the first candidate to enter a crucial stage of research in the US and sending it shares up 10 percent. The Cambridge, Mass.-based company’s Phase 3 trial will test its experimental inoculation in about 30,000 people at …
-
The feds placed a $2 billion order for 100 million doses of Pfizer’s potential coronavirus vaccine under the Trump administration’s push to have a shot ready by next year. Americans would receive Pfizer’s shots for free under the deal announced Wednesday — assuming the vaccine it’s developing with the German biotech firm BioNTech wins federal …
-
An early human trial of Oxford University’s experimental coronavirus vaccine has yielded a strong immune response in hundreds of people, according to newly released data. The potential vaccine, which the U.K. university developed in partnership with drugmaker AstraZeneca, was administered in a trial that involved 1,077 people and caused an immune response in people aged …
-
Biotech company Moderna announced on Tuesday that a potential coronavirus vaccine has produced a “robust” immune response in all patients participating in early vaccine trials. The trials centered on three groups of 45 patients, each of whom received the trial vaccine. While preliminary data from the trials was released in May, those results have now …
-
Prince William ventured out to visit an Oxford University coronavirus vaccine lab – becoming the first British royal to be seen wearing a face mask amid the pandemic, according to a report. Wearing a mask and googles, the Duke of Cambridge met “guinea pigs” testing the vaccine on Wednesday and told researchers that their work …
-
Probably people in the country where the first effective vaccine is developed. About a dozen different vaccines are in various stages of testing worldwide, including in Britain, China and the U.S. This week, Dr. Anthony Fauci, the top U.S. infectious disease expert, said he is cautiously optimistic there will be a COVID-19 vaccine by the …
As many as one in three Americans say they would not get a vaccine for the coronavirus even if it were approved by the FDA and available for free. About 35 percent of Americans say they would not receive such a vaccine to guard against the coronavirus, while 65 percent say they would plan to …
